On February 26, 2021 GlycoMimetics, Inc. (Nasdaq: GLYC), reported that executives from the Company plan to participate in three virtual healthcare conferences in March (Press release, GlycoMimetics, FEB 26, 2021, View Source [SID1234575768]). More information about the presentations and panel discussions will be available on the Company’s website, under the Investors tab. Details are as follows:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen 41st Annual Health Care Conference
March 1 – March 4, 2021
Eric Feldman, M.D., GlycoMimetics Vice President, Clinical Development, to participate in Leukemias Panel
Wed, March 3, 2021, 11:40 a.m. – 12:40 p.m. (EST)
Access to the panel discussion is for registered attendees only.

H.C. Wainwright Global Life Sciences Conference
March 9 – 10, 2021
Rachel King, GlycoMimetics CEO, to present a corporate overview
The presentation will be available on-demand, beginning at 7 a.m. ET, March 9 through March 10. Access will be provided through the Company’s website (Investors section) and archived for 90 days.

33rd Annual Virtual Roth Conference
March 15 – 17, 2021
Rachel King, GlycoMimetics CEO, to present a corporate overview
Mon, March 15, 10:00 a.m. – 12:00 p.m. (EST) in Virtual 2 (Panel: Navigating Clinical Development in Rare Hematology & Inflammatory Disease). A link to the panel session will be available in the Investors section of the GlycoMimetics website.